Marshall Wace, LLP Evolus, Inc. Transaction History

Marshall Wace, LLP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $171,912 - $226,365	-16,451 Reduced 7.54%	201,849 $2.19 Million
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $3.35 Million - $5 Million	-335,226 Reduced 60.56%	218,300 $3.06 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $925,908 - $1.28 Million	-121,830 Reduced 18.04%	553,526 $5.83 Million
Q3 2023 Nov 14, 2023	SELL	$7.15 - $10.2 $2.58 Million - $3.69 Million	-361,518 Reduced 34.87%	675,356 $6.17 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $6.69 Million - $9.74 Million	925,963 Added 834.87%	1,036,874 $7.54 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $866,214 - $1.23 Million	110,911 New	110,911 $938,000
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $1.45 Million - $2.56 Million	186,874 New	186,874 $1.51 Million
Q2 2022 Aug 15, 2022	SELL	$10.22 - $13.94 $172,748 - $235,627	-16,903 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $88,233 - $199,117	16,903 New	16,903 $190,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $1.37 Million - $2.14 Million	-255,537 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$7.36 - $13.67 $1.71 Million - $3.18 Million	-232,882 Reduced 47.68%	255,537 $1.95 Million
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $1.85 Million - $3.08 Million	220,296 Added 82.16%	488,419 $6.18 Million
Q1 2021 May 17, 2021	BUY	$3.2 - $16.51 $857,993 - $4.43 Million	268,123 New	268,123 $3.48 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.